(4-Methyl-1,2,5-oxadiazol-3-yl)acetic acid(CAS: 15323-69-0)

The regulatory guidelines for (4-Methyl-1,2,5-oxadiazol-3-yl)acetic acid (CAS: 15323-69-0) include GHS classification for safety data sheets, REACH regulations for European manufacturers, and FDA/EPA requirements for pharmaceutical and environmental safety. Compliance with these guidelines ensures safe handling, storage, and disposal of the compound.

There are several alternatives to (4-Methyl-1,2,5-oxadiazol-3-yl)acetic acid in synthesis, including (2-Methyl-1,3,4-oxadiazol-5-yl)acetic acid and (3-Methyl-1,2,4-oxadiazol-5-yl)acetic acid. These alternatives can be used as effective substitutes depending on the specific requirements of the reaction.

The market for (4-Methyl-1,2,5-oxadiazol-3-yl)acetic acid (CAS: 15323-69-0) is currently stable with increasing interest in its use in pharmaceuticals and as a reagent in organic synthesis. Research trends include its application in drug discovery and development, with ongoing studies focusing on its biological activity and potential medicinal uses.

Waste containing (4-Methyl-1,2,5-oxadiazol-3-yl)acetic acid (CAS: 15323-69-0) should be collected in appropriate containers and stored separately. Incineration or professional waste disposal services are recommended for ultimate disposal. Ensure all waste management practices comply with local, state, and federal regulations to protect the environment and public health.